Spots Global Cancer Trial Database for Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC
Official Title: Chemoradiotherapy With or Without Sintilimab in Limited-stage Small Cell Lung Cancer: a Multicenter Prospective Randomized Phase II Trial
Study ID: NCT04189094
Conditions
Study Description
Brief Summary: The study is a prospective, multi-center, open-label, randomized, and controlled phase II clinical trial.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Ming Chen, MD. PhD.
Affiliation: Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
